Cinacalcet as alternative treatment for primary hyperparathyroidism: achievements and prospects

ISSN： 1355-008X

Source： Endocrine, Vol.39, Iss.3, 2011-06, pp. : 199-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful treatment of inoperable recurrent secondary hyperparathyroidism with cinacalcet HCl

By Eriguchi Rieko Umakoshi Junko Tominaga Yoshihiro Sato Yuzuru

NDT PLUS, Vol. 1, Iss. 4, 2008-08 ,pp. : 218-220

Oxford University Press

Access to resources Recommend Favorite

Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism

By Faggiano A.

Endocrine, Vol. 39, Iss. 3, 2011-06 ,pp. : 283-287

Springer Publishing Company

Access to resources Recommend Favorite

Prolonged hypocalcaemia following a single dose of 60 mg denosumab in two patients with CKD 4/5 on cinacalcet treatment for tertiary hyperparathyroidism

By Ivanov Petko Khedr Milad

Clinical Kidney Journal, Vol. 6, Iss. 2, 2013-04 ,pp. : 245-245

Oxford University Press

Access to resources Recommend Favorite

Cinacalcet HCl Suppresses Cyclin D1 Oncogene-Derived Parathyroid Cell Proliferation in a Murine Model for Primary Hyperparathyroidism

By Imanishi Yasuo

Calcified Tissue International, Vol. 89, Iss. 1, 2011-07 ,pp. : 29-35

Springer Publishing Company

Access to resources Recommend Favorite

Azathioprine as an alternative treatment in primary hypophysitis

By Papanastasiou L.

Pituitary, Vol. 14, Iss. 1, 2011-03 ,pp. : 16-22

Springer Publishing Company

Access to resources Recommend Favorite